Literature DB >> 17431594

Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients.

Venkata Radhakrishna Kondepati1, H Michael Heise.   

Abstract

Implementing strict glycemic control can reduce the risk of serious complications in both diabetic and critically ill patients. For this reason, many different analytical, mainly electrochemical and optical sensor approaches for glucose measurements have been developed. Self-monitoring of blood glucose (SMBG) has been recognised as being an indispensable tool for intensive diabetes therapy. Recent progress in analytical instrumentation, allowing submicroliter samples of blood, alternative site testing, reduced test time, autocalibration, and improved precision, is comprehensively described in this review. Continuous blood glucose monitoring techniques and insulin infusion strategies, developmental steps towards the realization of the dream of an artificial pancreas under closed loop control, are presented. Progress in glucose sensing and glycemic control for both patient groups is discussed by assessing recent published literature (up to 2006). The state-of-the-art and trends in analytical techniques (either episodic, intermittent or continuous, minimal-invasive, or noninvasive) detailed in this review will provide researchers, health professionals and the diabetic community with a comprehensive overview of the potential of next-generation instrumentation suited to either short- and long-term implantation or ex vivo measurement in combination with appropriate body interfaces such as microdialysis catheters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431594     DOI: 10.1007/s00216-007-1229-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  10 in total

1.  Injectable hydrogel microbeads for fluorescence-based in vivo continuous glucose monitoring.

Authors:  Hideaki Shibata; Yun Jung Heo; Teru Okitsu; Yukiko Matsunaga; Tetsuro Kawanishi; Shoji Takeuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  In vivo, transcutaneous glucose sensing using surface-enhanced spatially offset Raman spectroscopy: multiple rats, improved hypoglycemic accuracy, low incident power, and continuous monitoring for greater than 17 days.

Authors:  Ke Ma; Jonathan M Yuen; Nilam C Shah; Joseph T Walsh; Matthew R Glucksberg; Richard P Van Duyne
Journal:  Anal Chem       Date:  2011-11-02       Impact factor: 6.986

3.  TheClinical Research Tool: a high-performance microdialysis-based system for reliably measuring interstitial fluid glucose concentration.

Authors:  Gregor Ocvirk; Martin Hajnsek; Ralph Gillen; Arnfried Guenther; Gernot Hochmuth; Ulrike Kamecke; Karl-Heinz Koelker; Peter Kraemer; Karin Obermaier; Cornelia Reinheimer; Nina Jendrike; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

Review 4.  Single-walled carbon nanotube-based near-infrared optical glucose sensors toward in vivo continuous glucose monitoring.

Authors:  Kyungsuk Yum; Thomas P McNicholas; Bin Mu; Michael S Strano
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

5.  Compatibility of Nitric Oxide Release with Implantable Enzymatic Glucose Sensors Based on Osmium (III/II) Mediated Electrochemistry.

Authors:  Kyoung Ha Cha; Mark E Meyerhoff
Journal:  ACS Sens       Date:  2017-08-23       Impact factor: 7.711

6.  Intravascular glucose/lactate sensors prepared with nitric oxide releasing poly(lactide-co-glycolide)-based coatings for enhanced biocompatibility.

Authors:  Qinyi Yan; Terry C Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biosens Bioelectron       Date:  2011-04-22       Impact factor: 10.618

Review 7.  Recent progress in mechanical artificial pancreas.

Authors:  Masami Hoshino; Yoshikura Haraguchi; Iwanori Mizushima; Motohiro Sakai
Journal:  J Artif Organs       Date:  2009-09-19       Impact factor: 1.731

8.  Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia.

Authors:  Kathleen M Dungan; Wen Han; Anthony Miele; Trisha Zeidan; Karen Weiland
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

9.  Metabolic tumor profiling with pH, oxygen, and glucose chemosensors on a quantum dot scaffold.

Authors:  Christopher M Lemon; Peter N Curtin; Rebecca C Somers; Andrew B Greytak; Ryan M Lanning; Rakesh K Jain; Moungi G Bawendi; Daniel G Nocera
Journal:  Inorg Chem       Date:  2013-10-21       Impact factor: 5.165

Review 10.  Electrochemical Sensors for Clinic Analysis.

Authors:  You Wang; Hui Xu; Jianming Zhang; Guang Li
Journal:  Sensors (Basel)       Date:  2008-03-27       Impact factor: 3.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.